Skip to main content
OpenTrials

Clinical trial condition

Chronic Phase Chronic Myeloid Leukemia

Explore clinical trials studying Chronic Phase Chronic Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

9 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Chronic Phase Chronic Myeloid Leukemia trial results

Recruiting

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

NCT03934372

Conditions
Accelerated Phase Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, +31 more
Locations
  • Ghent University Hospital Ghent, Belgium
  • Hopital Robert Debre Paris, France
  • Armand Trousseau Hospital Paris, France
  • Centre Hospitalier Universitaire de Poitiers Poitiers, France
View all 23 locations
View Trial Details
Completed

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

NCT01593254

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Local Institution - 0004 Anaheim, California, United States
  • Local Institution - 0006 Fontana, California, United States
  • University Of Southern California University Hospital Los Angeles, California, United States
  • Local Institution - 0110 Roseville, California, United States
View all 101 locations
View Trial Details
Completed

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States

NCT03045120

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Mount Sinai Hospital Chicago, Illinois, United States
  • Alexian Brothers Medical Center Elk Grove Village, Illinois, United States
  • The Cancer Institute At Alexian Brothers Elk Grove Village, Illinois, United States
  • Northwest Oncology & Hematology, SC Hoffman Estates, Illinois, United States
View all 24 locations
View Trial Details
Completed

Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response

NCT01850004

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Local Institution - 0006 Duarte, California, United States
  • Local Institution - 0029 Los Angeles, California, United States
  • Local Institution - 0001 San Franisco, California, United States
  • Local Institution - 0013 Chicago, Illinois, United States
View all 28 locations
View Trial Details
Completed

Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response

NCT01933906

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung Wels, Upper Austria, Austria
  • Universitätskliniken Innsbruck, Univ.-Klinik f.Innere Medizin V Hämtologie u. Onkologie Innsbruck, Austria
  • Ordensklinikum Linz - Elisabethinen Linz, Austria
  • Universitätsklinikum der PMU Salzburg, Universitätsklinik für Innere Medizin III Salzburg, Austria
View Trial Details
Completed

Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib

NCT01660906

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Pacific Cancer Medical Center Anaheim, California, United States
  • Cancer Center Of Central Connecticut Southington, Connecticut, United States
  • St. Agnes Healthcare, Inc. Baltimore, Maryland, United States
  • Promedica Hematology & Oncology Assoicates Sylvania, Ohio, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

NCT03610971

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +13 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory -Winship Cancer Institute Atlanta, Georgia, United States
  • Memorial Sloan Kettering - Bergen Montvale, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details

Related conditions